Linerixibat GLISTEN study now enrolling

Linerixibat GLISTEN study now enrolling

Linerixibat GLISTEN study now enrolling

The GLISTEN clinical trial is investigating a potential new treatment specifically for PBC itch and is now enrolling patients worldwide.  In Canada, the study is currently enrolling in Toronto and Ottawa, Ontario. PBC patients interested in participating can find out more about the study and how to enroll- in English or in French.